PharmaBlock Sciences Nanjing Inc
SZSE:300725

Watchlist Manager
PharmaBlock Sciences Nanjing Inc Logo
PharmaBlock Sciences Nanjing Inc
SZSE:300725
Watchlist
Price: 35.06 CNY -2.77% Market Closed
Market Cap: 7B CNY
Have any thoughts about
PharmaBlock Sciences Nanjing Inc?
Write Note

Relative Value

The Relative Value of one PharmaBlock Sciences Nanjing Inc stock under the Base Case scenario is 69.52 CNY. Compared to the current market price of 35.06 CNY, PharmaBlock Sciences Nanjing Inc is Undervalued by 50%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
69.52 CNY
Undervaluation 50%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
82
vs Industry
35
Median 3Y
6.4
Median 5Y
13.1
Industry
2.5
Forward
3.7
vs History
61
vs Industry
15
Median 3Y
40.4
Median 5Y
54.6
Industry
21.8
Forward
31.9
vs History
88
vs Industry
17
Median 3Y
42.7
Median 5Y
72.1
Industry
16.1
vs History
vs Industry
32
Median 3Y
6.5
Median 5Y
10.3
Industry
23.8
vs History
85
vs Industry
38
Median 3Y
3.9
Median 5Y
7
Industry
2.1
vs History
84
vs Industry
35
Median 3Y
7
Median 5Y
12.9
Industry
2.7
Forward
3.7
vs History
80
vs Industry
26
Median 3Y
15.8
Median 5Y
27.2
Industry
5.2
vs History
80
vs Industry
16
Median 3Y
44.3
Median 5Y
60.6
Industry
13.5
Forward
16.8
vs History
80
vs Industry
19
Median 3Y
44.3
Median 5Y
60.6
Industry
16.8
Forward
24.7
vs History
88
vs Industry
18
Median 3Y
44.9
Median 5Y
70
Industry
15.2
vs History
44
vs Industry
4
Median 3Y
-42.3
Median 5Y
-29.5
Industry
19.3
vs History
84
vs Industry
41
Median 3Y
3.2
Median 5Y
6.1
Industry
1.9

Multiples Across Competitors

Competitors Multiples
PharmaBlock Sciences Nanjing Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CN
PharmaBlock Sciences Nanjing Inc
SZSE:300725
7B CNY 4.5 39.8 35.9 35.9
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
756.3B USD 18.5 90.4 48.5 54.2
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
DK
Novo Nordisk A/S
CSE:NOVO B
2.7T DKK 10.2 29 20.2 23
US
Johnson & Johnson
NYSE:JNJ
349.7B USD 4 23.8 11.5 15
US
Merck & Co Inc
NYSE:MRK
251.6B USD 4 20.7 10.5 12.5
CH
Roche Holding AG
SIX:ROG
200.1B CHF 3.4 17.4 9.8 11.6
UK
AstraZeneca PLC
LSE:AZN
162.1B GBP 4.1 31.5 169.4 253.9
CH
Novartis AG
SIX:NOVN
171.5B CHF 3.8 10.8 9.4 13.1
US
Pfizer Inc
NYSE:PFE
151.4B USD 2.5 35.6 10.6 16
P/E Multiple
Earnings Growth P/E to Growth
CN
PharmaBlock Sciences Nanjing Inc
SZSE:300725
Average P/E: 33.2
39.8
69%
0.6
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 347 888.9 N/A N/A
US
Eli Lilly and Co
NYSE:LLY
90.4
446%
0.2
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A N/A
DK
Novo Nordisk A/S
CSE:NOVO B
29
86%
0.3
US
Johnson & Johnson
NYSE:JNJ
23.8
-23%
N/A
US
Merck & Co Inc
NYSE:MRK
20.7
7 300%
0
CH
Roche Holding AG
SIX:ROG
17.4
54%
0.3
UK
AstraZeneca PLC
LSE:AZN
31.5
177%
0.2
CH
Novartis AG
SIX:NOVN
10.8
31%
0.3
US
Pfizer Inc
NYSE:PFE
35.6
719%
0
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
CN
PharmaBlock Sciences Nanjing Inc
SZSE:300725
Average EV/EBITDA: 417.2
35.9
103%
0.3
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 459 134.4 N/A N/A
US
Eli Lilly and Co
NYSE:LLY
48.5
195%
0.2
UK
Dechra Pharmaceuticals PLC
LSE:DPH
3 846.3
151%
25.5
DK
Novo Nordisk A/S
CSE:NOVO B
20.2
84%
0.2
US
Johnson & Johnson
NYSE:JNJ
11.5
14%
0.8
US
Merck & Co Inc
NYSE:MRK
10.5
331%
0
CH
Roche Holding AG
SIX:ROG
9.8
23%
0.4
UK
AstraZeneca PLC
LSE:AZN
169.4
64%
2.7
CH
Novartis AG
SIX:NOVN
9.4
8%
1.2
US
Pfizer Inc
NYSE:PFE
10.6
31%
0.3
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
CN
PharmaBlock Sciences Nanjing Inc
SZSE:300725
Average EV/EBIT: 1 813.8
35.9
52%
0.7
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 046 864.6 N/A N/A
US
Eli Lilly and Co
NYSE:LLY
54.2
211%
0.3
UK
Dechra Pharmaceuticals PLC
LSE:DPH
17 702.3
675%
26.2
DK
Novo Nordisk A/S
CSE:NOVO B
23
83%
0.3
US
Johnson & Johnson
NYSE:JNJ
15
28%
0.5
US
Merck & Co Inc
NYSE:MRK
12.5
675%
0
CH
Roche Holding AG
SIX:ROG
11.6
28%
0.4
UK
AstraZeneca PLC
LSE:AZN
253.9
131%
1.9
CH
Novartis AG
SIX:NOVN
13.1
58%
0.2
US
Pfizer Inc
NYSE:PFE
16
68%
0.2

See Also

Discover More
Back to Top